We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+3.2%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$112M
AUM Growth
+$2.51M
Cap. Flow
-$831K
Cap. Flow %
-0.74%
Top 10 Hldgs %
18.4%
Holding
164
New
24
Increased
48
Reduced
65
Closed
13

Top Buys

Rank Stock Value
1
DORM icon
Dorman Products
DORM
+$925K
2
FUL icon
H.B. Fuller
FUL
+$909K
3
WST icon
West Pharmaceutical
WST
+$805K
4
PG icon
Procter & Gamble
PG
+$778K
5
CAG icon
Conagra Brands
CAG
+$760K

Top Sells

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$1.15M
2
BAX icon
Baxter International
BAX
+$952K
3
NTRS icon
Northern Trust
NTRS
+$934K
4
TGT icon
Target
TGT
+$806K
5
SPXC icon
SPX Corp
SPXC
+$711K

Sector Composition

Rank Sector Weight
1 Industrials 23.8%
2 Healthcare 16.26%
3 Energy 13.01%
4 Financials 11.23%
5 Consumer Staples 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$618B
$3.08M 2.76%
29,454
-340
-1% -$34.4K
CHD icon
2
Church & Dwight Co
CHD
$23.4B
$2.71M 2.43%
77,600
-1,900
-2% -$65.3K
XOM icon
3
ExxonMobil
XOM
$644B
$2.67M 2.39%
26,541
-246
-0.9% -$24.8K
GE icon
4
GE Aerospace
GE
$374B
$2.13M 1.91%
16,937
-527
-3% -$67K
QCOM icon
5
Qualcomm
QCOM
$155B
$1.81M 1.63%
22,915
+5,630
+33% +$448K
AMGN icon
6
Amgen
AMGN
$208B
$1.74M 1.56%
14,725
+1,450
+11% +$168K
TKR icon
7
Timken Company
TKR
$9.56B
$1.74M 1.56%
35,805
-4,533
-11% -$205K
IHG icon
8
InterContinental Hotels
IHG
$23.9B
$1.72M 1.54%
29,054
-7,801
-21% -$407K
BAX icon
9
Baxter International
BAX
$13.5B
$1.53M 1.37%
39,075
-23,795
-38% -$952K
CNI icon
10
Canadian National Railway
CNI
$76.9B
$1.39M 1.24%
21,350
-1,850
-8% -$110K
ESV
11
DELISTED
Ensco Rowan plc
ESV
$1.37M 1.23%
6,175
– –
DINO icon
12
HF Sinclair
DINO
$16.3B
$1.33M 1.19%
30,465
+8,290
+37% +$407K
IBM icon
13
IBM
IBM
$211B
$1.32M 1.18%
7,604
-21
-0.3% -$3.78K
OXY icon
14
Occidental Petroleum
OXY
$56.8B
$1.31M 1.17%
13,308
-235
-2% -$22.1K
EMR icon
15
Emerson Electric
EMR
$83.9B
$1.29M 1.16%
19,446
– –
BNS icon
16
Scotiabank
BNS
$107B
$1.27M 1.14%
20,378
-8,357
-29% -$483K
MRO
17
DELISTED
Marathon Oil Corporation
MRO
$1.27M 1.13%
31,750
-1,200
-4% -$44.3K
INDB icon
18
Independent Bank
INDB
$3.99B
$1.25M 1.12%
32,447
+2,280
+8% +$85.4K
UL icon
19
Unilever
UL
$137B
$1.23M 1.1%
24,044
-11,645
-33% -$584K
HON icon
20
Honeywell
HON
$77B
$1.22M 1.09%
14,579
-223
-2% -$18.6K
COP icon
21
ConocoPhillips
COP
$147B
$1.21M 1.08%
14,100
-800
-5% -$62.3K
PB icon
22
Prosperity Bancshares
PB
$8.97B
$1.18M 1.05%
18,800
+9,075
+93% +$549K
MRK icon
23
Merck
MRK
$322B
$1.17M 1.05%
21,207
-367
-2% -$20K
CELG
24
DELISTED
Celgene Corp
CELG
$1.16M 1.04%
13,480
-2,150
-14% -$164K
MHK icon
25
Mohawk Industries
MHK
$7.5B
$1.15M 1.03%
8,325
+1,375
+20% +$186K
1
2 3 4 5

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return

New England Research & Management's Q2 2014 Portfolio in Review

As of Q2 2014, New England Research & Management held 164 positions worth $112M, up 2.3% from $109M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

New England Research & Management's Q2 2014 filing shows 24 new, 48 increased, 65 reduced and 13 closed positions. Its largest new stake was Dorman Products: 16,950 shares worth $836K. The largest sale was Freeport-McMoran, an estimated $1.15M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Energy.

  • New England Research & Management's largest Q2 2014 buy was Dorman Products: 16,950 shares worth $836K.
  • New England Research & Management added most to Procter & Gamble in Q2 2014, an estimated $778K increase.
  • New England Research & Management's biggest Q2 2014 reduction was Baxter International, cutting an estimated $952K.
  • New England Research & Management fully exited Freeport-McMoran in Q2 2014, selling an estimated $1.15M.
  • New England Research & Management's ten largest holdings make up 18% of its $112M portfolio in Q2 2014.
  • New England Research & Management opened 24 new positions and closed 13 in Q2 2014.
  • New England Research & Management's portfolio value rose 2.3% quarter-over-quarter to $112M.

Based on New England Research & Management's 13F filing for Q2 2014, filed 1 Jul 2014.